Virginia National Bankshares Corporation VABK Increase Decrease In Receivables

Increase Decrease In Receivables at other companies

AbCellera Biologics Inc.ABCL

-$13.1M-1,256%

ZumiezZUMZ

-$777K-203%

ICF InternationalICFI

$2.85M+113%

V2XVVX

$90.7M+1,495%

BioCryst PharmaceuticalsBCRX

$474K-96.6%

Lithium AmericasLAC

$585K+760%

Other financials

Income statement

See full

Revenue$14.4M+2.4%

Net income$5.3M+17.2%

EPS (diluted)$0.97+16.9%

Balance sheet

See full

Total debt$25.8M+3.2%

Total equity$186.5M+11.8%

Total assets$1.6B+0.9%

Cash flow

See full

Operating cash flow$7.2M+246%

CapEx$207.0K-20.1%

Free cash flow$7.0M+284%

Valuation

See full

Market cap$240.65M+20.8%

P/E12×+0.9×

P/S4.2×+0.6×

Profitability

See full

Net margin34.6%+2.1pp

FCF margin44.8%+20.7pp

Returns & leverage

See full

Return on equity11.3%+0.2pp

Debt / equity0.1×0.0×

Where this comes from

Reported directly by Virginia National Bankshares Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.

The official record: Virginia National Bankshares Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Virginia National Bankshares Corporation's increase decrease in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Virginia National Bankshares Corporation's increase decrease in receivables?: Virginia National Bankshares Corporation (VABK) reported increase decrease in receivables of -$679K in Q1 2026.
How has Virginia National Bankshares Corporation's increase decrease in receivables changed year-over-year?: Virginia National Bankshares Corporation's increase decrease in receivables decreased by 123.2% year-over-year, from $2.92M to -$679K.